Federico Grossi Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Federico Grossi is Chief Medical Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 94,884 shares of APLS, which is worth approximately $2.6 Million. The most recent transaction as insider was on Jan 05, 2023, when has been sold 2,500 shares (Common Stock) at a price of $48.79 per share, resulting in proceeds of $121,975. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.9K

0% 3M change

0% 12M change

Total Value Held $2.6 Million

Federico Grossi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2023	SELL Open market or private sale	$121,975 $48.79 p/Share	2,500 Reduced 2.57%	94,884 Common Stock
Dec 01 2022	SELL Open market or private sale	$124,825 $49.93 p/Share	2,500 Reduced 2.5%	97,384 Common Stock
Nov 01 2022	SELL Open market or private sale	$152,075 $60.83 p/Share	2,500 Reduced 2.44%	99,884 Common Stock
Oct 03 2022	SELL Open market or private sale	$166,725 $66.69 p/Share	2,500 Reduced 2.38%	102,384 Common Stock
Sep 01 2022	SELL Open market or private sale	$150,750 $60.3 p/Share	2,500 Reduced 2.33%	104,884 Common Stock
Aug 01 2022	SELL Open market or private sale	$139,975 $55.99 p/Share	2,500 Reduced 2.28%	107,384 Common Stock
Jun 01 2022	SELL Open market or private sale	$104,450 $41.78 p/Share	2,500 Reduced 2.23%	109,561 Common Stock
May 02 2022	SELL Open market or private sale	$108,900 $43.56 p/Share	2,500 Reduced 2.18%	112,061 Common Stock
Apr 21 2022	SELL Other acquisition or disposition	-	1,875 Reduced 1.61%	114,561 Common Stock
Mar 15 2022	SELL Open market or private sale	$14,839 $39.57 p/Share	375 Reduced 0.32%	116,436 Common Stock
Mar 15 2022	BUY Exercise of conversion of derivative security	$30,170 $4.31 p/Share	7,000 Added 5.65%	116,811 Common Stock
Mar 01 2022	SELL Open market or private sale	$16,324 $43.53 p/Share	375 Reduced 0.34%	109,811 Common Stock
Feb 23 2022	BUY Exercise of conversion of derivative security	$17,671 $4.31 p/Share	4,100 Added 3.59%	110,186 Common Stock
Feb 15 2022	SELL Open market or private sale	$17,036 $45.43 p/Share	375 Reduced 0.35%	106,086 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	$15,516 $4.31 p/Share	3,600 Added 3.27%	106,461 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$33,220 $47.12 p/Share	705 Reduced 0.68%	102,861 Common Stock
Feb 01 2022	SELL Open market or private sale	$15,218 $40.58 p/Share	375 Reduced 0.36%	103,566 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$25,084 $38.59 p/Share	650 Reduced 0.62%	103,941 Common Stock
Jan 21 2022	BUY Grant, award, or other acquisition	-	26,051 Added 19.94%	104,591 Common Stock
Jan 14 2022	SELL Open market or private sale	$15,210 $40.56 p/Share	375 Reduced 0.48%	78,540 Common Stock
Jan 14 2022	BUY Exercise of conversion of derivative security	$14,654 $4.31 p/Share	3,400 Added 4.13%	78,915 Common Stock
Jan 12 2022	BUY Exercise of conversion of derivative security	$20,850 $4.04 p/Share	5,161 Added 6.4%	75,515 Common Stock
Jan 03 2022	SELL Open market or private sale	$17,741 $47.31 p/Share	375 Reduced 0.53%	70,354 Common Stock
Dec 15 2021	SELL Open market or private sale	$16,080 $42.88 p/Share	375 Reduced 0.53%	70,729 Common Stock
Dec 08 2021	BUY Exercise of conversion of derivative security	$26,320 $3.76 p/Share	7,000 Added 8.96%	71,104 Common Stock

Federico Grossi

Chief Medical Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account